Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria (CSU) drug into phase 2, instead preparing ...

Third Harmonic Bio (NASDAQ:THRD) will be liquidating the company and selling its remaining assets, the company said on Monday ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who ...

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it ...

Contact urticaria is localized color changes and swelling on the skin that appear immediately after coming into contact with a specific substance. Contact urticaria can result from a variety of ...

Don’t have a sun allergy? These recommendations still apply to you. If you’ve never heard of a sun allergy, you’re not alone. This idea was foreign to me until a few weeks ago, when I broke out in ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody placulumab, and positive results from the phase 3 studies of remibrutinib.

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for ...

The following is a summary of “Dupilumab Improves Urticaria-Specific Quality of Life in Patients with Chronic Spontaneous ...